Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)
- Written by PR Newswire
Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301.
MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is proud to announce that...